Progenics takes space on 47th floor of One World Trade Center

11 January 2016

Progenics Pharmaceuticals has signed a 14 year lease for 26,500 square feet of space on the 47th floor of One World Trade Center. Progenics is a biotech firm specializing in cancer and HIV medications. The lease was signed with the buildings owner, the Durst Organization and the Port Authority of New York and New Jersey , for $78 per square foot. Durst representatives say that 2 million of the tower’s 3 million square feet of space has already been leased. Patricia Ardigo and Joel Wechsler of CBRE represented the Progenics with Cushman & Wakefield representing the landlord.

Example banner for displaying an ad. It can be higher.